Hisamitsu Pharmaceutical co.,inc.

Salonpas® Care of People around the World with PATCH

Products

・SALONPAS® PAIN RELIEF PATCH
・SALONPAS® ARTHRITIS PAIN
・SALONPAS®
・SALONPAS® LARGE
・SALONPAS® HOT
and more….

SALONPAS® PAIN RELIEF PATCH / SALONPAS® ARTHRITIS PAIN is the First and Only FDA-Approved OTC pain relieving patch. Two powerful ingredients, ‘Methyl Salicylate and Menthol’, go right to the site of pain. SALONPAS®PAIN….

R&D

Hisamitsu Pharmaceutical Co., Inc. has organized effective research & development (R&D) systems, with four major centers that enable prompt….

Select your region

North America

North America

Branch

U.S.A.

Subsidiary company

Country of sale

U.S.A.
Canada

Click here for region page

Central & South America

Central & South America

Subsidiary company

Hisamitsu Farmaceutica do Brasil Ltda.

Country of sale

Brazil
Chile
Costa Rica
Panama
Bolivia

Click here for region page

Asia & Oseania

Asia & Oseania

Branch

Singapore
Taiwan

Subsidiary company

Hisamitsu Vietnam Pharmaceutical Co., Ltd.
PT.Hisamitsu Pharma Indonesia

Country of sale

Guam
Australia
Thailand
Philippines
Malaysia
Hong Kong
Sri Lanka
Vietnam
Indonesia
Singapore
Taiwan

Click here for region page

Middle East & Africa

Middle East & Africa

Country of sale

UAE
Oman
Qatar
Kuwait
Saudi Arabia
Bahrain
Jordan
Lebanon
Mauritius

Click here for region page

Europe

Europe

Subsidiary company

Hisamitsu UK Limited

Country of sale

Italy
Greece
Sweden
Hungary
Portugal
Russia

Click here for region page

2012.04.25(15KB): Results of a Japanese Phase III Clinical Study of HTU-520 (Terbinafine Hydrochloride Patch): A Therapeutic Agent for Tinea Unguium
2012.04.10: FY02/2012 Q4 Results Earnings Release Presentation
2012.04.03(12KB): Announcement on Launching the Topical Analgesic Patch “SALONPAS” in Chinese market
2012.03.28(36KB): Notice of Appointment of Executive Officer
2012.03.28(36KB): Notice of Proposed Changes of Directors

Copyright © 2003-2012 Hisamitsu Pharmaceutical Co.,Inc. All rights reserved.